Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitis

References

• Sleisenger F. Nonalcoholic steatohepatitis: gastrointestinal and liver disease 7th ed. Philadelphia: Saunders; 2002;2: 1349–400.
   Google Scholar
• Harrison SA. Nonalcoholic steatohepatitis: what we know in the new millennium. Am J Gastroenterol 2002; 97: 2714–24
   PubMed Web of Science ®Google Scholar
• Neuschwander-tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 2003; 37: 1202–19
   PubMed Web of Science ®Google Scholar
• Diehl AM. Nonalcoholic steatohepatitis. Semin Liver Dis 1999; 19: 221–9
   PubMed Web of Science ®Google Scholar
• Agrawal S, Bonkovsky HL. Management of nonalcoholic steatohepatitis. J Clin Gastroenterol 2002; 35: 253–61
   PubMed Web of Science ®Google Scholar
• Lin HZ, Yang SQ. Current biochemical studies of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis suggest a new therapeutic approach. Am J Gastroenterol 2003; 98: 2093–7
   PubMed Web of Science ®Google Scholar
• Lieber CS, Leo MA. Model of nonalcoholic steatohepatitis. Am J Clin Nutr 2004; 79: 502–9
   PubMed Web of Science ®Google Scholar
• McCullough AJ. Update on nonalcoholic fatty liver disease. J Clin Gastroenterol 2002; 34: 255–62
   PubMed Web of Science ®Google Scholar
• Metha K, VanThiel DH. Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutr Rev 2002; 60: 289–93
   PubMed Web of Science ®Google Scholar
• Harrison SA, Di Bisceglie AM. Advances in the understanding and treatment of nonalcoholic fatty liver disease. Drugs 2003; 63: 2379–94
   PubMed Web of Science ®Google Scholar
• Day CP, James OFW. Steatohepatitis: a tale of two “hits”?. Gastroenterology 1998; 114: 842–5
   PubMed Web of Science ®Google Scholar
• Chitturi S, Farrel GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001; 21: 27–41
   PubMed Web of Science ®Google Scholar
• Kleiner DE, Brunt EM. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41: 1313–21
   PubMed Web of Science ®Google Scholar
• Walsh MJ, Vanags DM, Clouston AD. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury. Hepatology 2004; 39: 1230–8
   PubMed Web of Science ®Google Scholar
• Yin M, Wheeler MD, Kono H. Essential role of tumor necrosis factor α in alcohol-induced liver injury in mice. Gastroenterology 1999; 117: 942–52
   PubMed Web of Science ®Google Scholar
• McClain CJ, Hill D. Cytokines and alcoholic liver disease. Semin Liver Dis 1993; 13: 170–82
   PubMed Web of Science ®Google Scholar
• Yang SQ, Lin HZ. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 1997; 94: 2557–62
   PubMed Web of Science ®Google Scholar
• Jaeschke H, Gores GJ. Mechanisms of hepatotoxicity. Toxicol Sci 2002; 65: 166–76
   PubMed Web of Science ®Google Scholar
• Soloman SS, Mishra SK. Pioglitazone and metformin reverse insulin resistance induced by tumor necrosis factor-alpha in liver cells. Horm Metab Res 1997; 29: 370–82
   Web of Science ®Google Scholar
• Satapathy SK, Garg S, Chauhan R. Beneficial effects of tumor necrosis factor-α inhibition by pentoxifylline on clinical, biochemical, and metabolic parameters of patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2004; 99: 1946–52
   PubMed Web of Science ®Google Scholar
• Adams LA, Zein CO. A pilot trial of pentoxifylline in nonalcoholic steatohepatitis. Am J Gastroenterol 2004; 99: 2365–8
   PubMed Web of Science ®Google Scholar
• Koppe SWP, Sahai A, Malladi P. Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet. J. Hepatol 2004; 41: 592–8
   Web of Science ®Google Scholar
• Hui JM, Hodge A. Beyond insulin resistance in NASH: TNF-alpha or adiponectin?. Hepatology 2004; 40: 46–54
   PubMed Web of Science ®Google Scholar
• Bahcecioglu IH, Yalniz M. Levels of serum hyaluronic acid, TNF-alpha and IL-8 in patients with nonalcoholic steatohepatitis. Hepatogastroenterology 2005; 52: 1549–53
   PubMedGoogle Scholar
• Starkel P, Sempoux C, Leclercq I. Oxidative stress, KLF6 and transforming growth β up-regulation differentiate non-alcoholic steatohepatitis progressing to fibrosis from uncomplicated steatosis in rats. J Hepatol 2003; 39: 538–46
   PubMed Web of Science ®Google Scholar
• Sepulveda-Flores RN, Vera-Cabrera L. Obesity-related non-alcoholic steatohepatitis and TGF-beta 1 serum levels in relation to morbid obesity. Ann Hepatol 2002; 1: 36–9
   PubMedGoogle Scholar
• Kugelmas M, Hill DB. Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 2003; 38: 413–9
   PubMed Web of Science ®Google Scholar
• Koruk M, Taysi S. Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. Ann Clin Lab Sci 2004; 34: 57–62
   PubMed Web of Science ®Google Scholar
• Fierbinteanu-Braticevici C, Bengus A. The risk factors of fibrosis in nonalcoholic steatohepatitis. Rom J Intern Med 2002; 40: 81–88
   PubMedGoogle Scholar
• Bahcecioglu IH, Yalniz M. Levels of serum vitamin A, alpha-tocopherol and malondialdehyde in patients with non-alcoholic steatohepatitis: relationship with histopathologic severity. Int J Clin Pract Mar 2005; 59: 318–23
   PubMed Web of Science ®Google Scholar
• Kanzler S, Galle PR. Apoptosis and liver. Semin Cancer Biol 2000; 10: 173–84
   PubMed Web of Science ®Google Scholar
• Rashid A, Wu T-C, Huang C-C. Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 1999; 29: 1131–8
   PubMed Web of Science ®Google Scholar
• Tsamandas AC, Thomopoulos K. Potential role of Bcl-2 and Bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study. Modern Pathol 2003; 16: 1273–88
   PubMed Web of Science ®Google Scholar
• Sorenson CM. Bcl-2 family members and disease. Biochimica Biophysica Acta 2004; 1644: 169–77
   PubMed Web of Science ®Google Scholar
• Frommel TO, Yong S. Immunohistochemical evaluation of Bcl-2 gene family expression in liver of hepatitis C and cirrhotic patients: a novel mechanism to explain the high incidence of hepatocarcinoma in cirrhotics. Am J Gastroenterol 1999; 94: 178–82
   PubMed Web of Science ®Google Scholar
• Laurent A, Nicco C. Pivotal role of superoxide anion and beneficial effect of antioxidant molecules in murine steatohepatitis. Hepatology 2004; 39: 1277–85
   PubMed Web of Science ®Google Scholar
• Ribeiro PS, Cortez-Pinto H. Hepatocyte apoptosis, expression of death receptors, and activation of NF-KB in the liver of nonalcoholic and alcoholic steatohepatitis patients. Am J Gastroenterol 2004; 99: 1708–17
   PubMed Web of Science ®Google Scholar